CHELSEA THERAPEUTICS INTERNATIONAL, LTD. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/070842e9-c76b-455f-a466-bfb3eaa36c99/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $-244.3M | 2002-04-03 – 2014-03-31 | evidence 0001144204-14-029111 |
| FY 2012 | $-223.7M | 2002-04-03 – 2013-03-31 | evidence 0001144204-13-025705 |
| FY 2011 | $-203.6M | 2002-04-03 – 2012-03-31 | evidence 0001193125-12-200720 |
| FY 2010 | $-37.5M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-101178 |
| FY 2009 | $-30.4M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-101178 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CHELSEA THERAPEUTICS INTERNATIONAL, LTD. — all facts · Net Income